Jmelnitzky A, Palazzolo A, Viola L, Landoni N, Morgante P, Chopita N, Romero G, Giulioni P
Cátedra de Gastroenterología de Post-Grado, Universidad Nacional de La Plata.
Acta Gastroenterol Latinoam. 1991;21(2):107-13.
Significance of endoscopic findings associated to esophageal varices (Japanese Research Society for Portal Hypertension) and hepatic dysfunction (Child-Pough classification) as predictive factors of variceal bleeding in cirrhotic patients is analyzed. In a cooperative prospective experience 137 cirrhotic patients with esophageal varices were examined in the period May 1987/89: 83 out of them had never bled from their varices (VENS group) while 54 recently had (VES group). A highly significative association was found between variceal size over 3 mm (grade II-III) and bleeding: 96.3% vs. 34.9% in VENS group (p = 0.01); similar association was found with regard to endoscopic detection of "red signs": 92.6% in bleeding group vs. 20.5% in VENS one (p = 0.01). "Red signs" were found on grade II-III varices in 98.5% of cases, and this association were related to variceal bleeding in 75.5%. Hepatic dysfunction was not directly related to bleeding episodes but "red signs" endoscopic detection in VENS group increased with liver function deterioration: 9.1% in Child A class, 27.3% in Child B, and 41.2% in Child C (p = 0.01). The strong association founded between bleeding and both grade II-III variceal size and "red signs" detection, suggest the possibility to identify a high risk group of cirrhotic patients candidate to prophylactic methodologies.
分析了与食管静脉曲张相关的内镜检查结果(日本门静脉高压研究学会)和肝功能障碍(Child-Pough分级)作为肝硬化患者静脉曲张出血预测因素的意义。在一项合作性前瞻性研究中,1987年5月至1989年期间对137例患有食管静脉曲张的肝硬化患者进行了检查:其中83例从未发生过静脉曲张出血(VENS组),而54例近期发生过出血(VES组)。发现静脉曲张直径超过3mm(II-III级)与出血之间存在高度显著相关性:VENS组中为96.3%,而未出血组为34.9%(p = 0.01);关于“红色征”的内镜检查发现也有类似相关性:出血组为92.6%,VENS组为20.5%(p = 0.01)。在98.5%的II-III级静脉曲张病例中发现了“红色征”,且这种相关性在75.5%的病例中与静脉曲张出血有关。肝功能障碍与出血事件无直接关联,但VENS组中“红色征”的内镜检查发现随肝功能恶化而增加:Child A级为9.1%,Child B级为27.3%,Child C级为41.2%(p = 0.01)。出血与II-III级静脉曲张大小和“红色征”检测之间存在的强相关性,提示有可能识别出适合预防性治疗方法的肝硬化高危患者群体。